Since the p27Kip1 abundance increased as a result of bortezomib treatment of CML cells, we investigated the effect of bortezomib on the stability of p27Kip1 using cycloheximide chase assay. The gene discussed is CDKN1B; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.